antibody-drug conjugate

antibody-drug conjugate

featured image of Genmab's $18bn Acquisition Boosts Cancer Pipeline
Companies

Genmab’s $18bn Acquisition Boosts Cancer Pipeline

BIOT

💥 Genmab is acquiring ProfoundBio for $1.8bn to expand its pipeline of antibody-drug conjugate therapies. 💊🏭🚀

Bioprocessupdates

©2023 - 2025 BioprocessUpdates

PRIVACY POLICY terms of service contact